Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Amgen Inc. Reports Strong Q4 Earnings with Revenue Surpassing Estimates

February 06, 2025
Amgen Inc., a leading biotechnology company, has reported impressive fourth-quarter earnings. The company's revenue exceeded estimates, reaching a staggering $9.1 billion. Additionally, their non-GAAP earnings per share (EPS) rose to $5.31.

Amgen's strong performance can be attributed to the success of its various innovative drug therapies. The company has been at the forefront of cancer treatment research, offering cutting-edge solutions for patients.

Recently, Cibc World Market Inc. sold their shares of Amgen Inc. on the NASDAQ stock exchange. This move has raised questions about the company's potential future growth. However, experts believe that Amgen Inc. remains a solid investment option in the biotech industry.

In fact, hedge funds have shown a keen interest in Amgen Inc., considering it as one of the best cancer stocks to buy. The company's commitment to groundbreaking research and development sets it apart from its competitors.

For investors looking to capitalize on the positive momentum of Amgen Inc., it is recommended to consult professionals from Stocks Prognosis. Their expert analysis and forecasts can provide valuable insights to make informed investment decisions.

Overall, Amgen Inc. continues to impress the market with its strong financial performance and innovative drug therapies. The company's focus on pushing the boundaries of medical advancements makes it a promising investment option for those interested in the biotech sector.
If you want to leave a comment, then you need Login or Register





Other data for AMGN

Related data

AMGNJuly 30, 2025Amgen Inc. NASDAQ:AMGN Shares Unloaded by Rep. Jefferson Shreve  ~1 min.

Recently, Representative Jefferson Shreve unloaded a significant number of Amgen Inc. (NASDAQ:AMGN) shares....


AMGNApril 22, 2025Amgen Inc. AMGN: Among the Innovative Healthcare Stocks to Watch in 2025  ~2 min.

Amgen Inc., a leading biotechnology company, is currently one of the most promising stocks in the healthcare sector....


AMGNMarch 20, 2025Hedge Funds Recommend Amgen Inc. AMGN as the Best Pharma Stock to Buy  ~1 min.

According to recent reports, hedge funds are strongly recommending Amgen Inc. (AMGN) as the best pharma stock to buy....


AMGNMarch 19, 2025Amgen Inc. AMGN: Cutting-Edge Biotech Company Dominates Stock Market  ~2 min.

Amgen Inc. (AMGN), renowned for its groundbreaking innovations in biotechnology, continues to make headlines as a leading player in the stock market....


AMGNMarch 17, 2025Amgen Inc. Continues to Impress Hedge Funds with Strong Performance  ~2 min.

Amgen Inc. (NASDAQ:AMGN) has emerged as the top choice for hedge funds looking to invest in the pharmaceutical sector....


AMGNMarch 16, 2025Amgen Inc. AMGN: Discover Why it's Among the Top Pharma Stocks to Buy  ~2 min.

Amgen Inc., a leading biotechnology company, has been gaining attention in the investment community due to its outstanding performance in the pharmaceutical sector....


AMGNMarch 10, 2025AMGEN INC. Hits Price Target Forecast with 20.7% Profit: A Success Story for QuantWave  ~1 min.

AMGEN INC. has recently reached the price target forecast set by QuantWave, resulting in a significant profit of 20.7% for investors who followed the predictive signal....


AMGNMarch 7, 2025AMGEN INC. Hits Price Target Forecast with 19.78% Profit, as Predicted by QuantWave  ~2 min.

AMGEN INC. (AMGN) recently achieved the price target forecast set by QuantWave, resulting in a profit of 19.78% for investors who followed the prediction....


AMGNFebruary 27, 2025Amgen Inc. AMGN: A Promising Investment Opportunity in the Pharmaceutical Industry  ~2 min.

Amgen Inc. (AMGN), a leading biotechnology company, is regarded as one of the best investment options in the pharmaceutical sector, according to analysts at Yahoo Finance....


AMGNFebruary 26, 2025Amgen Inc. AMGN: Among the Cheap Pharmaceutical Stocks to Buy According to Analysts  ~1 min.

Analysts have identified Amgen Inc. (NASDAQ:AMGN) as one of the cheap pharmaceutical stocks to buy....


AMGNDecember 26, 2024Amgen Inc. Continues to Attract Investors: Promising Outlook for AMGN  ~2 min.

Leading biotechnology company Amgen Inc. (NASDAQ:AMGN) has caught the attention of investors with its solid performance and positive market trends. In recent news, Principal Financial Group Inc....


BIIBMarch 19, 2025Biogen Inc. Reports Positive Earnings and Sees Rise in Stock Price  ~2 min.

Biogen Inc., a leading biotechnology company, recently released its earnings report for the last quarter. The company has shown impressive growth, with a 1....


BIIBFebruary 27, 2025Biogen Inc. BIIB: A Promising Future for the Biotech Giant  ~2 min.

Biogen Inc., a leading biotech company, is making waves in the stock market with its groundbreaking research and development....


AMGNNovember 24, 2024Amgen Inc. Continues to Lead in Immunotherapy: Experts Recommend Investing in Stocks Prognosis  ~2 min.

Amgen Inc. (NASDAQ: AMGN) has established itself as a frontrunner in immunotherapy research and development, making it a promising investment opportunity for shareholders....


BIIBJanuary 2, 2025Biogen Inc.: Revolutionizing Healthcare with Innovative Biotechnology  ~2 min.

Biogen Inc. (BIIB) is setting new standards in the healthcare industry with its groundbreaking biotechnology solutions....